🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, claiming the corporations withheld alleged dangers that the medication created to pediatric cognitive development.

The court filing follows a month after Former President Trump advocated an unverified association between taking Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is filing suit against Johnson & Johnson, which previously sold the medication, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which currently produces it.

In a declaration, he said they "betrayed America by profiting off of discomfort and marketing drugs without regard for the dangers."

The company asserts there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These companies misled for generations, intentionally threatening countless individuals to increase profits," Paxton, a Republican, declared.

The company commented that it was "deeply concerned by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the health of US mothers and children."

On its online platform, the company also stated it had "consistently assessed the pertinent research and there is lacking reliable evidence that demonstrates a verified association between consuming acetaminophen and autism spectrum disorder."

Organizations representing medical professionals and healthcare providers agree.

The American College of Obstetricians and Gynecologists has declared paracetamol - the main ingredient in acetaminophen - is one of the few options for expectant mothers to manage pain and fever, which can pose significant medical dangers if not addressed.

"In multiple decades of studies on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the use of acetaminophen in any period of gestation leads to brain development issues in children," the organization said.

The lawsuit references current declarations from the Trump administration in claiming the drug is reportedly hazardous.

In recent weeks, the former president caused concern from health experts when he advised expectant mothers to "fight like hell" not to consume Tylenol when sick.

The FDA then released a statement that physicians should contemplate reducing the usage of acetaminophen, while also stating that "a causal relationship" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Kennedy, who manages the Food and Drug Administration, had promised in April to undertake "extensive scientific investigation" that would establish the cause of autism in a short period.

But experts warned that finding a single cause of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism is a category of permanent neurological difference and condition that influences how individuals experience and interact with the surroundings, and is identified using doctors' observations.

In his legal document, Paxton - who supports Trump who is campaigning for federal office - alleges Kenvue and J&J "intentionally overlooked and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The case aims to force the firms "remove any marketing or advertising" that states Tylenol is safe for women during pregnancy.

The court case echoes the complaints of a collection of parents of young ones with autism spectrum disorder and ADHD who took legal action against the makers of acetaminophen in 2022.

A federal judge threw out the lawsuit, saying research from the family's specialists was not conclusive.